We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wireless Therapy Device Facilitates Drug Delivery

By HospiMedica International staff writers
Posted on 07 Jan 2015
A novel electronic implant triggered remotely by a wireless signal delivers heat to infected tissue, enhancing antibiotic release without reducing antibiotic activity.

Developed by researchers at Tufts University (Medford, MA, USA), the implantable therapeutic device was designed to counter Staphylococcus aureus infections. More...
The fully degradable, remotely controlled, therapeutic device can be left behind at a surgical or suturing site for infection management by either thermal treatment and/or by remote triggering of drug release when there is retardation of antibiotic diffusion, in deep infections, or when systemic antibiotic treatment alone is insufficient due to the emergence of antibiotic-resistant strains.

The device includes a serpentine resistor and a power-receiving heater coil made of magnesium that is inserted into a silk protein "pocket" that protected the electronics and controls the dissolution time. The packaging and electronics are turned on remotely after implantation, providing the necessary thermal therapy or to trigger drug delivery; after completion of function, the device is safely resorbed into the body, within a programmable period, obviating the need for secondary surgeries and retrieval. A study describing the device was published in the December 2014 issue of the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

“This is an important demonstration step forward for the development of on-demand medical devices that can be turned on remotely to perform a therapeutic function in a patient and then safely disappear after their use, requiring no retrieval,” said senior author Professor of Biomedical Engineering Fiorenzo Omenetto, PhD. “These wireless strategies could help manage postsurgical infection, for example, or pave the way for eventual 'wi-fi' drug delivery.”

Implantable medical devices typically use non-degradable materials that have limited operational lifetimes and must eventually be removed or replaced.

Related Links:

Tufts University



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Cardiograph Device
PageWriter TC35
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.